Drugs / [(11)C](-)-RWAY
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00263523 | Dec 2005 → Aug 2007 | — | National Institute of Mental Health (NIMH) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | [(11)C](-)-RWAY | “Therefore, we have recently developed \[(11)C\](-)-RWAY as an alternative radioligand for brain 5 HT(1A) receptors.” NCT00263523 ↗ |
| Modality | Diagnostic / imaging agent | “a newly developed radioligand (radioactive substance used in PET scanning to study the receptor systems of the brain)” NCT00263523 ↗ |
| Route | Intravenous | “the tracer is injected through a catheter (plastic tube) placed in the arm” NCT00263523 ↗ |